Cheryl Pinkleton, | |
13900 Hull Street Rd, Midlothian, VA 23112-2004 | |
(804) 639-8788 | |
Not Available |
Full Name | Cheryl Pinkleton |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 13900 Hull Street Rd, Midlothian, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386145878 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119000351 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cheryl Pinkleton, 13900 Hull Street Rd, Midlothian, VA 23112-2004 Ph: () - | Cheryl Pinkleton, 13900 Hull Street Rd, Midlothian, VA 23112-2004 Ph: (804) 639-8788 |
News Archive
Though world food prices "jumped to a record high" in the U.N. Food and Agriculture Organization's (FAO) latest index, the agency "is drawing comfort from the absence of widespread riots, usually the defining element of a food crisis," the Financial Times reports looking at the factors that have led some food prices to rise significantly without sparking international panic.
Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections.
The Indiana Network for Population Health has been launched by the Regenstrief Institute and collaborators, including the State of Indiana, Indiana University and the Indiana Health Information Exchange, to provide the secure exchange of comprehensive data - especially information on social determinants of health such as housing stability and access to nutritious food - to researchers, policy makers, healthcare providers and others on the front lines fighting opioid and other addictions.
Work-related stress encountered by construction workers and the impact it has on performance, the risk of accidents, and costs to employers will be investigated thanks to a £25,000 research grant.
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
› Verified 4 days ago
Lanetta Pressley, M.S.,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15008 Rosebay Forest Dr, Midlothian, VA 23112 Phone: 804-363-9756 | |
Independence By Design Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14318 Denby Ter, Midlothian, VA 23114 Phone: 804-794-1333 Fax: 804-379-8664 | |
Leah Reed, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13800 Bon Secours Dr, Midlothian, VA 23114 Phone: 804-712-1227 | |
Julie Diana Gronboldt, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14201 Broad Oaks Ct, Midlothian, VA 23112 Phone: 804-312-6154 | |
Michelle Wallace Allen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13424 Welby Ct, Midlothian, VA 23113 Phone: 804-986-7224 | |
Mrs. Claire Emory Rose, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Coalfield Rd, Midlothian, VA 23114 Phone: 804-897-7440 | |
Dustin Ryan Mays, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2100 Brandermill Pkwy, Midlothian, VA 23112 Phone: 804-379-7100 |